(MedPage Today) — The FDA has approved a new sublingual tablet formulation of the opioid addiction drug buprenorphine-naloxone (Zubsolv), drugmaker Orexo U.S. announced. (Source: MedPage Today Psychiatry)
FDA OKs New Formula for Addiction Drug
Call 1 (888) 460-6556 to speak with a counselor.
